The FDA cleared Access MeMed BV, a host-response blood test that helps distinguish bacterial from viral infections in adults and children in as little as 15 minutes.
Feature|Slideshows|August 22, 2024
8 Questions on Updates to the 2024 ACIP Adult Immunization Schedule
Author(s)Kenneth Bender, PharmD, MA
Do you know the ACIP-preferred influenza vaccine for adults aged ≥65 yrs? The cut-off age for HPV vaccination? The time between the 2-dose mpox series? More, here.
Advertisement
The 2024 ACIP (Advisory Committee on Immunization Practices) Adult Immunization Schedule1 was approved and released in January by the CDC (Centers for Disease Control and Prevention) with four new vaccines and accompanying notes that address special circumstances and eligibility criteria. The 8 questions above are drawn from the schedule for routine vaccinations, the notes on special circumstances, and from subsequent recommendations.2
References
1. Centers for Disease Control and Prevention (CDC), US Department of Health and Human Services. Recommended Adult Immunization Schedule2024.https://www.cdc.gov/vaccines/schedules/hcp/imz/adult.html . Accessed July 15, 2024.
2. Advisory Committee on Immunization Practices (ACIP). ACIP Recommendations. June 28, 2024. https://www.cdc.gov/vaccines/acip/recommendations.html .Accessed July 15, 2024.
Advertisement
Related to this article
Catch up on the 9 FDA drug approvals most relevant to primary care, including new options for HIV-1 infection, narcolepsy, diabetes, pain management, and more.
Evolocumab was associated with a 20% lower risk of fatal or nonfatal myocardial infarction than ezetimibe among more than 544 000 adults with ASCVD.
Greater Mediterranean diet adherence was associated with lower odds of adult acne, particularly among women, in a UK Biobank study of dietary patterns.
Abbott's investigational device achieved 96.3% complete left atrial appendage closure by echocardiography, with a 1.8% ischemic stroke rate at 1 year.
October FDA news included updates on long-acting olanzapine, multi-cancer blood testing, stroke rehabilitation, and heart failure monitoring.
Christoph Correll, MD, discusses the new once-monthly olanzapine injection for schizophrenia, including clinical efficacy, metabolic risks, and patient selection.
Cheryl Cox Kinney, MD, explains when night sweats warrant further evaluation, including red flags, persistent symptoms, and potential nonmenopausal causes.
Advertisement
Advertisement